• Log in with Facebook Log in with Twitter Log In with Google      Sign In    
  • Create Account
  LongeCity
              Advocacy & Research for Unlimited Lifespans
  • .org
  • Districts
  • Media
  • SupportUs
  • Collaborate
  • Contact
  • Search
  • Join


Adverts help to support the work of this non-profit organisation. To go ad-free join as a Member.


Photo

Assorted News (RegMed)

Started by caliban , Feb 19 2011 03:26 AM
regenerative medicine tissue engineering stemcells regmed

  • Please log in to reply
178 replies to this topic

#91 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 17 October 2012 - 06:49 PM

RegMed sector, prices up and volumes down; hops, skips and the jumps
Proactive Investors USA & Canada - 35 minutes ago
The 6 W's: Who, what, where, when, why and what of it … The RegMed sector trades narrowly … fractionally … “Up but, Mixed”… in choppy trading as it seems to be pulling stocks in opposite directions following yesterday and as seen over the course of ...

View the full article

#92 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 17 October 2012 - 09:22 PM

4 Biotechnology Stocks to Sell Now
Investorplace.com - 1 hour ago
The ratings of four Biotechnology stocks are down this week, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).

View the full article

#93 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 18 October 2012 - 01:46 PM

BioTime offers equity stake for Geron assets
MarketWatch - 2 hours ago
By Saabira Chaudhuri. In an open letter, BioTime Inc. (ASE:BTX) urged Geron Corp. (NASDAQ:GERN) shareholders to push Geron's board to sell the company's stem cell assets to BioTime.
BIOTIME, INC. : Issues Open Letter to Shareholders of Geron Corporation - 4-traders

View the full article

sponsored ad

  • Advert

#94 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 18 October 2012 - 07:12 PM

RegMed sector, nothing like a completed financing and an acquisition/financing ...
Proactive Investors USA & Canada - 4 hours ago
The 6 W's: Who, what, where, when, why and what of it … The RegMed sector has yet another mixed day. But, the “tiger fish in the tank are hungry” as BTX drops an “Open Letter on Geron (GERN) shareholders.

View the full article

#95 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 19 October 2012 - 01:08 PM

BIOTIME, INC. : LifeMap Sciences, Inc. Announces Addition to Board of ...
4-traders - 16 minutes ago
BioTime, Inc. : LifeMap Sciences, Inc. Announces Addition to Board of Directors and Provides Update on Product Portfolio Development.

View the full article

#96 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 18 October 2012 - 07:08 PM

BioTime (NYSE MKT: BTX) proposes stem cell assets acquisition deal – Issues ...
Proactive Investors USA & Canada - 21 hours ago
AN OPEN LETTER TO GERON SHAREHOLDERS. During 11/11, Geron (GERN) announced that it was discontinuing its stem cell research and development programs and its cliniCAl trials of OPC-1, a groundbreaking product to treat spinal cord injuries ...

View the full article

#97 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 19 October 2012 - 05:49 PM

Geron (GERN) versus BioTime (NYSE MKT: BTX), the pending war of letters ...
Proactive Investors USA & Canada - 13 hours ago
GERN acknowledged the public release by BTX of a letter to Geron's stockholders regarding stem cell assets. Geron's Board of Directors has, since the announcement that Geron would be discontinuing its stem cell research and development programs, ...

View the full article

#98 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 17 October 2012 - 09:22 PM

4 Biotechnology Stocks to Sell Now
Investorplace.com - Oct 17, 2012
The ratings of four Biotechnology stocks are down this week, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).

View the full article

#99 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 19 October 2012 - 01:08 PM

LifeMap Sciences Appoints Louis Silverman to Board of Directors
Benzinga - Oct 19, 2012
BioTime (NYSE: BTX) and its subsidiary, LifeMap Sciences, Inc., today announced the appointment of Louis E. Silverman to LifeMap Sciences' board of directors.

View the full article

#100 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 18 October 2012 - 08:01 PM

PropThink: Stem Cell Divestiture May Benefit Geron Shareholders More than the ...
Reuters - Oct 18, 2012
By Jake King. Geron Corp (NASDAQ:GERN) may have finally found a buyer for its suspended stem cell program. The company has been searching since November of 2011 when Geron halted the projects to focus on the development of Imetelstat and ...

View the full article

#101 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 19 October 2012 - 01:08 PM

BIOTIME, INC. : LifeMap Sciences, Inc. Announces Addition to Board of ...
4-traders - Oct 19, 2012
BioTime, Inc. : LifeMap Sciences, Inc. Announces Addition to Board of Directors and Provides Update on Product Portfolio Development.

View the full article

#102 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 19 October 2012 - 01:01 PM

LifeMap Sciences, Inc. Announces Addition to Board of Directors and Provides ...
MarketWatch (press release) - Oct 19, 2012
ALAMEDA, Calif., Oct 19, 2012 (BUSINESS WIRE) -- BioTime, Inc. (nyse mkt:BTX) and its subsidiary, LifeMap Sciences, Inc., today announced the appointment of Louis E. Silverman to LifeMap Sciences' board of directors.

View the full article

#103 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 19 October 2012 - 12:01 PM

Geron Acknowledges Letter to its Stockholders from BioTime
Reuters - Oct 19, 2012
MENLO PARK, Calif., October 19, 2012 -- Geron Corporation (Nasdaq: GERN) today acknowledged the public release by BioTime, Inc. (NYSE: BTX) of a letter to Geron's stockholders regarding Geron's stem cell assets.

View the full article

#104 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 18 October 2012 - 01:15 PM

BIOTIME, INC. : Issues Open Letter to Shareholders of Geron Corporation
4-traders - Oct 18, 2012
BioTime, Inc. : Issues Open Letter to Shareholders of Geron Corporation. 10/18/2012| 09:15am US/Eastern. BioTime, Inc. (NYSE MKT: BTX) today issued the following letter to the shareholders of Geron Corporation (Nasdaq: GERN) regarding Geron's stem ...

View the full article

#105 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 22 October 2012 - 07:29 PM

RegMed sector, a cherry picked market
Proactive Investors USA & Canada - 2 hours ago
The 6 W's: Who, what, where, when, why and what of it … The RegMed sector turned barely higher after a weak open Monday, looking to recover after their biggest week decline since June.

View the full article

#106 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 19 October 2012 - 01:14 PM

LifeMap Sciences, Inc. Announces Addition To Board Of Directors And Provides ...
TheStreet.com (press release) - Oct 19, 2012
Mr. Silverman is an experienced health care executive with board level and operating experience in health care IT, pharmaceuticals, home health care, worker's compensation managed care and revenue cycle management.

View the full article

#107 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 19 October 2012 - 07:56 PM

1 Stem-Cell Spinout You Must Watch
DailyFinance - Oct 19, 2012
Nearly a year after Geron (NAS: GERN) said it was shuttering its stem cell program, the biotech has a buyer if it wants. Buyer being a relative term.

View the full article

#108 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 23 October 2012 - 04:30 PM

BIOTIME, INC. : BioTime's Subsidiary LifeMap Sciences, Inc. Announces the ...
4-traders - 2 hours ago
BioTime, Inc. : BioTime's Subsidiary LifeMap Sciences, Inc. Announces the Launch of MalaCards - A Database of Human Diseases. 10/23/2012| 12:30pm US/Eastern.

View the full article

#109 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 19 October 2012 - 11:52 AM

GERON CORPORATION : Geron Acknowledges Letter to its Stockholders from ...
4-traders - Oct 19, 2012
Geron Corporation : Geron Acknowledges Letter to its Stockholders from BioTime. 10/19/2012| 07:50am US/Eastern. MENLO PARK, Calif.

View the full article

#110 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 23 October 2012 - 07:42 PM

RegMed sector, take me out of the game coach, our team is getting clubbed
Proactive Investors USA & Canada - 3 hours ago
The 6 W's: Who, what, where, when, why and what of it … The RegMed sector stocks added to losses across the board Tuesday. The Dow was slumping -250 points … now trailing lower <-217>with the NASDAQ down <-37> now -18 <so far>, following a ...

View the full article

#111 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 23 October 2012 - 12:01 PM

Geron Announces Conference Call to Discuss Third Quarter 2012 Financial ...
Reuters - Oct 23, 2012
Menlo Park, Calif., October 23, 2012 - Geron Corporation (Nasdaq: GERN) will announce its financial results for the third quarter ended September 30, 2012 on Tuesday, October 30, 2012, after the market close.

View the full article

#112 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 19 October 2012 - 01:31 PM

LifeMap Sciences, Inc. Announces Addition to Board of Directors and Provides ...
DailyFinance - Oct 19, 2012
LifeMap Sciences, Inc. Announces Addition to Board of Directors and Provides Update on Product Portfolio Development. ALAMEDA, Calif.

View the full article

#113 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 19 October 2012 - 05:49 PM

Geron (GERN) versus BioTime (NYSE MKT: BTX), the pending war of letters ...
Proactive Investors USA & Canada - Oct 19, 2012
GERN acknowledged the public release by BTX of a letter to Geron's stockholders regarding stem cell assets. Geron's Board of Directors has, since the announcement that Geron would be discontinuing its stem cell research and development programs, ...

View the full article

#114 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 25 October 2012 - 02:58 PM

Ex-Geron chief spearheads bid to revive mothballed stem cell studies
FierceBiotech - 1 hour ago
Back in early 2011 Geron CEO Thomas Okarma was forced to step aside as the biotech prepared to bring in a new CEO to restructure the operations, putting a leading stem cell program in mothballs and pushing a more narrow focus on cancer drugs--which ...

View the full article

#115 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 23 October 2012 - 04:30 PM

BIOTIME, INC. : BioTime's Subsidiary LifeMap Sciences, Inc. Announces the ...
4-traders - Oct 23, 2012
BioTime, Inc. : BioTime's Subsidiary LifeMap Sciences, Inc. Announces the Launch of MalaCards - A Database of Human Diseases. 10/23/2012| 12:30pm US/Eastern.

View the full article

#116 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 23 October 2012 - 07:42 PM

RegMed sector, take me out of the game coach, our team is getting clubbed
Proactive Investors USA & Canada - Oct 23, 2012
The 6 W's: Who, what, where, when, why and what of it … The RegMed sector stocks added to losses across the board Tuesday. The Dow was slumping -250 points … now trailing lower <-217>with the NASDAQ down <-37> now -18 <so far>, following a ...

View the full article

#117 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 24 October 2012 - 04:20 AM

BioTime's Subsidiary LifeMap Sciences, Inc. Announces the Launch of ...
EON: Enhanced Online News (press release) - Oct 24, 2012
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX) and LifeMap Sciences, Inc. announce the launch of MalaCards, a new database of human diseases that is based on their leading GeneCards® platform.

View the full article

#118 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 26 October 2012 - 06:40 PM

RegMed sector, little has changed but, TGIF
Proactive Investors USA & Canada - 2 hours ago
The 6 W's: Who, what, where, when, why and what of it … The RegMed sector … has no cover as the NASDAQ wavers … in a narrow range however, a positive point … the Athersys (ATHX) secondary offering … GOT DONE … at $1.01 … with the over ...

View the full article

#119 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 25 October 2012 - 02:58 PM

Ex-Geron chief spearheads bid to revive mothballed stem cell studies
FierceBiotech - Oct 25, 2012
Back in early 2011 Geron CEO Thomas Okarma was forced to step aside as the biotech prepared to bring in a new CEO to restructure the operations, putting a leading stem cell program in mothballs and pushing a more narrow focus on cancer drugs--which ...

View the full article

#120 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 01 November 2012 - 01:06 PM

BioTime Subsidiary OrthoCyte Corporation Announces the Appointment of ...
The Herald | HeraldOnline.com - 7 minutes ago
ALAMEDA, Calif. - BioTime, Inc. (NYSE MKT: BTX) and its subsidiary OrthoCyte Corporation today announced the appointment of Francois Binette, PhD, as OrthoCyte's Vice President of Research and Business Development.

View the full article
Back to Ventures & Markets



Also tagged with one or more of these keywords: regenerative medicine, tissue engineering, stemcells, regmed

0 user(s) are reading this topic

0 members, 0 guests, 0 anonymous users

  1. LONGECITY
  2. → Round Table Discussion
  3. → Business
  4. → Ventures & Markets
  5. site rules